← Leaderboards
Jose Alejandro Guevara-Patino
H. Lee Moffitt Cancer Ctr & Res Inst
$4,617,045
Attributed
$4,797,679
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $777K · FY2008–24$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,797,679 · 6
By mechanism
R01$3,351,049 · 2
R21$1,148,951 · 3
P01$297,679 · 1
Top collaborators
- Michael I Nishimura2 shared
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Shari Pilon-Thomas$5,168,533
- Eric B. Haura$11,744,471
- Amod Sarnaik$826,070
- Jose R Conejo-Garcia$21,497,732
- Maclean Hall$113,944
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteMelanomaSignal TransductionTumorMalignant NeoplasmsResponseCd8b1 GeneImmuneCellsReceptorTumor GrowthPathway InteractionsTumor ImmunityMemoryClinical TrialsCd4 Positive T LymphocytesIn VivoMelanoma CellAgonistT Memory CellEngineeringMolecularT-Cell ReceptorAdoptive Cell Transfers
Grant awards (16)
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells$357,915
R01 · FY2024 · CA · contact PI
Exploratory Study of T Cell Skin Trafficking and the Role of NKG2D Signaling; Implications in Vitiligo and Melanoma$407,770
R21 · FY2023 · AR · contact PI
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells$369,216
R01 · FY2023 · CA · contact PI
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells$369,216
R01 · FY2022 · CA · contact PI
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells$344,757
R01 · FY2021 · CA · contact PI
Study of Anti-Tumor Immunity and Tissue Resident Memory Cell Development by NKG2D and Ribosomal Protein S6 Signaling in T cells$343,320
R01 · FY2020 · CA · contact PI
Rescuing Anti-tumor Responses of TCR-Td T Cells by NKG2D-stimulation$313,325
R01 · FY2018 · CA · contact PI
Rescuing Anti-tumor Responses of TCR-Td T Cells by NKG2D-stimulation$313,325
R01 · FY2017 · CA · contact PI
Rescuing Anti-tumor Responses of TCR-Td T Cells by NKG2D-stimulation$313,325
R01 · FY2016 · CA · contact PI
Rescuing Anti-tumor Responses of TCR-Td T Cells by NKG2D-stimulation$313,325
R01 · FY2015 · CA · contact PI
TCR/DAP10 chimera as a means to attaining persistent anti-tumor T cell responses$197,055
R21 · FY2015 · CA · contact PI
Rescuing Anti-tumor Responses of TCR-Td T Cells by NKG2D-stimulation$313,325
R01 · FY2014 · CA · contact PI
TCR/DAP10 chimera as a means to attaining persistent anti-tumor T cell responses$164,213
R21 · FY2014 · CA · contact PI
Impact of AICD on TCR Transduced T Cells for Adoptive Immunotherapy$297,679
P01 · FY2012 · CA · contact PI
Disparate suppression of naive effector and memory T cells in tumor-bearing hosts$172,688
R21 · FY2009 · CA · contact PI
Disparate suppression of naive effector and memory T cells in tumor-bearing hosts$207,225
R21 · FY2008 · CA · contact PI